Opportunities for biotech await in the Amazon rainforest
01 May, 2023 by Emily Newton*As deforestation continues in the Amazon rainforest, humanity could permanently lose an untold number of life-changing drugs.
Micropore Pathfinder for development of RNA/LNP therapeutics and vaccines
01 May, 2023Harnessing the capabilities of Micropore's AXF mini, together with intuitive software, the AXF Pathfinder is a compact benchtop unit for discovery, development and phase 1 clinical development through to full GMP manufacture of nucleic acid therapeutics and vaccines.
Flexible gold sensor promising for medical implants
27 April, 2023Researchers have produced a film-like sensor that is both flexible and sensitive enough to enable a more streamlined future for electronic medical implants.
Wireless pacemakers may be safe for children
26 April, 2023Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats.
An RNA encapsulation facility in your hand
18 April, 2023The Micropore AXF (Advanced Cross Flow) range is expected to make a significant contribution to improving the performance of entire nanoparticle manufacturing processes.
Creating a genetic medicine manufacturing ecosystem: part 4
10 April, 2023 by Peter DavisWe are on the precipice of an explosion in local manufacturing of genetic medicines on a scale never seen before, with global equitable access.
Moderna launches programs to support mRNA research
24 March, 2023Moderna has announced its inaugural Australian Fellowship Program to support scientists with an interest in advancing mRNA innovation, while also partnering with UQ on vaccines for public health threats.
Breakthrough bone cancer drug could increase survival rate
20 March, 2023UK researchers have developed a new drug that works against all of the main types of primary bone cancer, which is usually very difficult to treat.
Targeted drug delivery to treat brain tumours in children
15 March, 2023Novel technology allows for the enhanced delivery of anticancer drugs to the specific locations of brain tumours while sparing normal brain regions.
Hydrogel stem cell treatment repairs brain tissue in mice
06 March, 2023The hydrogel keeps stem cells alive for long enough to allow them to evolve into the cells required to create new tissue in the damaged part of the body.
'Forgotten' drug revisited as potential leukaemia treatment
23 February, 2023The drug, called PIK-75, was initially discovered over a decade ago but was dismissed in favour of newer ones.
$96m RNA facility coming to Macquarie University
22 February, 2023Myeloid Therapeutics will collaborate with the NSW Government to create a world-class RNA manufacturing and research facility at Macquarie University.
PrEP implant could enable long-term HIV protection
20 February, 2023Researchers have been collaborating on an injectable implant that can release HIV PrEP medications into the body over a long period of time, with promising results.
UQ vaccine to protect pigs from Japanese encephalitis virus
16 February, 2023UQ-developed chimera virus technology was used to make a 'hybrid' version of the virus, using a mosquito-only Australian virus that is harmless to humans.
Milestone as scientists regenerate diseased kidney
15 February, 2023Blocking a damaging and scar-regulating protein called interleukin-11 (IL-11) enables damaged kidney cells to regenerate, restoring impaired kidney function.
